OncoSec Medical Inc (ONCSQ)

[akhsv777]

I am not that optimistic...yes, it could happen, but as one of the long term investors of this company, I would rather see PPS jump gradually, orderly - sustainable jump.

Over the recent years, there has been an immuno-oncology deal frenzy as big pharma jockey for position in the space. The number of companies left with experience and promising candidates without a partnership is dwindling fast.

The combinations are limitless and can provide an Avenue for big pharma companies to test their target of choice to elicit an immune response.

The ability to turn non-responders into responders through the addition of IL-12 would be a true game changer not only for ONCS but Merck as well. With 60-70% melanoma patients don't respond to checkpoint inhibitors, if ONCS shows just similar results demonstrated during the initial trial, FDA may not hesitate to grant accelerated approval in 2019 and Merck may not hesitate to sign a big partnership deal or even acquire ONCS.